Contribution of IL-32 gene expression to viral persistence
Contribution of IL-32 gene expression to viral persistence
批准号:
10177863
负责人:
CRAIG E. CAMERON
金额:
$18.95万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-03 至 2023-05-31
关键词:
AffinityAntibodiesAntiviral AgentsAntiviral ResponseAvidityBiomedical EngineeringCardiac MyocytesCardiomyopathiesCell Culture TechniquesCell LineCell NucleusCellsChronicCollaborationsComplementary DNACoxsackie VirusesCoxsackievirus InfectionsCulture MediaCytolysisCytoplasmDevelopmentEpithelial CellsGene ExpressionGene Expression ProfilingGenesGenotypeGoalsGrantHela CellsHumanHuman poliovirusImmuneImmunityInfectionInflammationInnate Immune ResponseInterferon-alphaInterferon-betaInterferonsKnock-outKnowledgeMeasles virusMediator of activation proteinModelingMolecularNonlyticPathway interactionsPharmacologyPhenotypePopulationPredispositionProtein IsoformsProteomicsPublic HealthRNA VirusesRegimenSystemTherapeuticTimeToll-like receptorsUp-RegulationViralViral AntigensVirusVirus DiseasesVirus ReplicationWorkacute infectionbasechronic infectionexperimental studygene discoveryinduced pluripotent stem cellinhibitor/antagonistpathogenpersonalized medicineprogramsprophylacticresponsesensorsingle cell analysistranscriptome
中文摘要
项目摘要
一个案件正在为实用程序的MeV持久性发展的终身免疫力。思想
除免疫细胞外,上皮细胞的持续感染可产生病毒或病毒性免疫缺陷。
抗原以促进抗体的亲和力成熟足够的持续时间,
产生最高的亲合力。上皮细胞中表型的形成是由什么决定的
是否有助于建立持续性感染尚不清楚。然而,这样的细胞应该能够
以抑制但不消除病毒增殖,并且病毒释放必须通过非裂解性的
机制,以避免慢性炎症的状态。在这种情况下,持续存在的-
感染感受态上皮细胞及其基因表达,特别是参与控制
病毒增殖,是理解病毒持久性的分子基础的重要的第一步。
我们对脊髓灰质炎病毒(PV)感染的单细胞分析显示,HeLa细胞群相当活跃,
在感染后长达36小时不裂解的情况下,能够熟练地支持PV增殖,
实验的持续时间。我们制定了一项策略来隔离这个持续存在的亚群-
通过向培养物中加入PV进入抑制剂,使用标准细胞培养方法感染细胞
媒体我们观察到PV持续时间长达6天感染后,再次的持续时间,
实验对这些持续感染细胞的基因表达分析显示,
抑制病毒和其他病原体的传感器,包括Toll样受体和“免费”
(胞质)受体18. IL-32的基因被诱导7倍(P值<0.001)。IL-32已被
与独立于I型和II型干扰素(IFN)的抗病毒应答有关;然而,
IL-32依赖性抗病毒途径的效应物尚未发现。的首要目标
我们将在R21基金的赞助下启动的项目是阐明基因,途径,
和病毒持久性所需的机制。本申请的第一个目标是鉴定
可能有助于建立CVB 3在人心肌细胞中的持久性。的第二个目标
该应用激发了IL-32作用机制的假说。将努力实现这些目标
本研究的主要目的是:(1)发现与CVB 3在人体内持续存在有关的基因
(2)发现HeLa细胞中IL-32依赖性抗病毒状态的效应子。
英文摘要
Project Abstract
A case is being made for the utility of MeV persistence in development of lifelong immunity. The thought
is that persistent infection of epithelial cells, in addition to immune cells, may produce virus or viral
antigens to promote affinity maturation of antibodies for a sufficient duration of time that antibodies of
the highest avidity are produced. What governs establishment of a phenotype in an epithelial cell
conducive to establishment of a persistent infection is not known. However, such a cell should be able
to suppress but not eliminate virus multiplication, and virus release must occur by a non-lytic
mechanism to avoid a state of chronic inflammation. Establishing the existence of such persistent-
infection-competent epithelial cells and their gene expression, especially genes involved in control of
virus multiplication, is an essential first step in understanding the molecular basis of viral persistence.
Our single-cell analysis of poliovirus (PV) infection revealed a population of HeLa cells that were quite
proficient at supporting PV multiplication without lysis for as long as 36 h post-infection, which was the
duration of the experiment. We developed a strategy to isolate this sub-population of persistently-
infected cells using standard cell-culture approaches by adding an inhibitor of PV entry to the culture
media. We observed PV persistence for as long as six days post-infection, again the duration of the
experiment. Gene-expression analysis of these persistently-infected cells revealed a near-complete
suppression of sensors of viruses and other pathogens, including Toll-like receptors and “toll-free”
(cytosolic) receptors18. The gene for IL-32 was induced 7 fold (P-value <0.001). IL-32 has been
implicated in antiviral responses that are independent of type I and II interferons (IFNs); however,
effectors of the IL-32-dependent, antiviral pathway have yet to be discovered. The overarching goal of
the program that we will initiate under the auspices of this R21 grant is elucidation of genes, pathways,
and mechanisms required for viral persistence. The first goal of this application is to identify genes that
may contribute to establishment of persistence of CVB3 in human cardiomyocytes. The second goal of
this application is to inspire hypotheses for the mechanism of IL-32 action. These goals will be pursued
as indicated by the following aims: (1) Discover genes contributing to CVB3 persistence in human
cardiomyocytes; and (2) Discover effectors of the IL-32-dependent antiviral state in HeLa cells.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.bioactmat.2022.01.046
发表时间:
2022-08
期刊:
Bioactive materials
影响因子:
18.9
作者:
[Jiang Y, Hoenisch RC, Chang Y, Bao X, Cameron CE, Lian XL]
通讯作者:
Lian XL
Enteroviral 2C protein as a therapeutic target
-
批准号:10609524
-
项目类别:
-
资助金额:$74.79万
-
财政年份:2022
-
负责人:CRAIG E. CAMERON
-
依托单位:
Enteroviral 2C protein as a therapeutic target
-
批准号:10450381
-
项目类别:
-
资助金额:$78.96万
-
财政年份:2022
-
负责人:CRAIG E. CAMERON
-
依托单位:
Core C: Enzymology Core
-
批准号:10513682
-
项目类别:
-
资助金额:$746.26万
-
财政年份:2022
-
负责人:CRAIG E. CAMERON
-
依托单位:
Optimizing nucleoside analog efficacy with novel exonuclease inhibitors
-
批准号:10514274
-
项目类别:
-
资助金额:$627.12万
-
财政年份:2022
-
负责人:CRAIG E. CAMERON
-
依托单位:
Contribution of IL-32 gene expression to viral persistence
-
批准号:10057016
-
项目类别:
-
资助金额:$24.24万
-
财政年份:2020
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:10021287
-
项目类别:
-
资助金额:$68.25万
-
财政年份:2019
-
负责人:CRAIG E. CAMERON
-
依托单位:
RNA-dependent RNA Polymerase
-
批准号:10017543
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2019
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:10640512
-
项目类别:
-
资助金额:$4.82万
-
财政年份:2019
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:10447359
-
项目类别:
-
资助金额:$53.4万
-
财政年份:2019
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:10331323
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2019
-
负责人:CRAIG E. CAMERON
-
依托单位:
Forms of HCV NS5A in vivo
-
批准号:8321157
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2012
-
负责人:CRAIG E. CAMERON
-
依托单位:
Forms of HCV NS5A in vivo
-
批准号:8432444
-
项目类别:
-
资助金额:$18.57万
-
财政年份:2012
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:8072938
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2010
-
负责人:CRAIG E. CAMERON
-
依托单位:
RNA-dependent RNA Polymerase
-
批准号:8072954
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2010
-
负责人:CRAIG E. CAMERON
-
依托单位:
Mechanisms of RNA binding and remodeling proteins
-
批准号:8321573
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2009
-
负责人:CRAIG E. CAMERON
-
依托单位:
Mechanisms of RNA binding and remodeling proteins
-
批准号:8312798
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2009
-
负责人:CRAIG E. CAMERON
-
依托单位:
Mechanisms of RNA binding and remodeling proteins
-
批准号:8133089
-
项目类别:
-
资助金额:$44.81万
-
财政年份:2009
-
负责人:CRAIG E. CAMERON
-
依托单位:
Mechanisms of RNA binding and remodeling proteins
-
批准号:7923334
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2009
-
负责人:CRAIG E. CAMERON
-
依托单位:
Phosphorimager Replacement
-
批准号:7595456
-
项目类别:
-
资助金额:$16.26万
-
财政年份:2009
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:6836487
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2003
-
负责人:CRAIG E. CAMERON
-
依托单位:
海外基金